Literature DB >> 33156083

Advocating the Development of Next-Generation, Advanced-Design Low-Field Magnetic Resonance Systems.

Val M Runge1, Johannes T Heverhagen.   

Abstract

New next-generation low-field magnetic resonance imaging systems (operating in the range of 0.5 T) hold great potential for increasing access to clinical diagnosis and needed health care both in developed countries and worldwide. The relevant history concerning the choice of field strength, which resulted in 1.5 T still dominating today the number of installed systems, is considered, together with design advances possible because of interval developments, since low field was considered for clinical use in the 1980s, and current research. The potential impact of low-cost, advanced-generation low-field magnetic resonance imaging systems, properly designed, is high in terms of further dissemination of health care-across the gamut from industrial to developing countries-regardless of disease entity and anatomic region of involvement, with major niche applications likely as well.

Mesh:

Year:  2020        PMID: 33156083     DOI: 10.1097/RLI.0000000000000703

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

Review 1.  [Imaging of the musculoskeletal system using low-field magnetic resonance imaging].

Authors:  Tobias Pogarell; Matthias S May; Armin M Nagel; Michael Uder; Rafael Heiss
Journal:  Radiologe       Date:  2022-04-13       Impact factor: 0.635

2.  Fast Quantitative Low-Field Magnetic Resonance Imaging With OPTIMUM-Optimized Magnetic Resonance Fingerprinting Using a Stationary Steady-State Cartesian Approach and Accelerated Acquisition Schedules.

Authors:  Mathieu Sarracanie
Journal:  Invest Radiol       Date:  2022-04-01       Impact factor: 10.065

Review 3.  [New clinical applications for low-field magnetic resonance imaging : Technical and physical aspects].

Authors:  Hanns-Christian Breit; Jan Vosshenrich; Michael Bach; Elmar M Merkle
Journal:  Radiologe       Date:  2022-02-22       Impact factor: 0.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.